Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.
Latest full-year results from official filings.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Credible news about incidents, disputes, legal action or restructuring in the last 24 months.
No adverse media involving ScreenPoint Medical found in HSH's search of the last 24 months. Apr 2026: it raised $16m, mainly from existing investors Insight Partners and Siemens Healthineers.
Data breaches, cyber incidents, regulator action and assurance status.
No data breaches, cyber incidents or regulator actions involving ScreenPoint Medical found in HSH's search of the last 24 months. NHS DSPT status not yet checked.
Recalls, safety notices, regulator action and clinical safety concerns.
No recalls, safety notices or regulator actions involving ScreenPoint Medical or Transpara found in HSH's search of the last 24 months.
Contract delivery, go-lives, terminations and disputes.
No contract disputes, terminations or notable NHS/UK contracts involving ScreenPoint Medical found in HSH's search of the last 24 months.